Literature DB >> 7932082

Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation.

R Zangerle1, M Sarcletti, H Gallati, G Reibnegger, H Wachter, D Fuchs.   

Abstract

We investigated 63 individuals with HIV infection, 34 of whom were asymptomatic (nine had oral candidiasis, four had constitutional signs and symptoms, and 16 had AIDS), for plasma lipids, soluble tumor necrosis factor receptor 75 (sTNF-R75) and other immune activation markers, namely urinary neopterin, beta 2-microglobulin, and the CD4+ T cell count. The median CD4+ T cell count was 318 x 10(6)/L. All individuals were allowed to have light breakfast in the morning; the venipuncture for the plasma lipids was done between 11 a.m. and 3 p.m.. Decreased plasma concentrations were found for total cholesterol, and HDL and LDL cholesterol in 3.2%, 46%, and 56% of the subjects, respectively. Plasma triglyceride levels were increased in 31.7% of the study population. The frequency and the extent of the decrease of HDL and LDL cholesterol and the increase in triglyceride levels were greater in those with a CD4+ T cell count below the median (p = 0.003, p = 0.05, and p = 0.01); when comparing individuals with CD4+ T cell counts above and below 500 x 10(6)/L (19 individuals), a difference was only found for HDL cholesterol (p = 0.01). Plasma levels of triglycerides correlated significantly however weakly with serum concentrations of sTNF-R75 (rs = 0.32, p = 0.01) but not at all with urinary neopterin or serum beta 2-microglobulin. HDL cholesterol correlated inversely with sTNF-R75 (rs = -0.53, p < 0.0001) and to a lesser extent with urinary neopterin (rs = -0.46, p = 0.0003) and beta 2-microglobulin (rs = -0.34, p = 0.008).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7932082

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  21 in total

1.  Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors.

Authors:  Madhu N Rao; Grace A Lee; Carl Grunfeld
Journal:  Am J Infect Dis       Date:  2006-09-30

Review 2.  Managing the metabolic and morphologic complications of HIV.

Authors:  M Keith Rawlings; Guillermo Santos
Journal:  J Natl Med Assoc       Date:  2004-02       Impact factor: 1.798

3.  Blood lipids, infection, and inflammatory markers in the Tsimane of Bolivia.

Authors:  Sarinnapha Vasunilashorn; Eileen M Crimmins; Jung Ki Kim; Jeff Winking; Michael Gurven; Hillard Kaplan; Caleb E Finch
Journal:  Am J Hum Biol       Date:  2010 Nov-Dec       Impact factor: 1.937

4.  Dyslipidemia and adherence to the Mediterranean diet in Croatian HIV-infected patients during the first year of highly active antiretroviral therapy.

Authors:  Drago Turcinov; Christine Stanley; Jesse A Canchola; George W Rutherford; Thomas E Novotny; Josip Begovac
Journal:  Coll Antropol       Date:  2009-06

Review 5.  Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.

Authors:  Joel da Cunha; Luciana Morganti Ferreira Maselli; Ana Carolina Bassi Stern; Celso Spada; Sérgio Paulo Bydlowski
Journal:  World J Virol       Date:  2015-05-12

6.  Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy.

Authors:  Fiona C Lampe; Daniel A Duprez; Lewis H Kuller; Russell Tracy; James Otvos; Erik Stroes; David A Cooper; Jennifer Hoy; Nick I Paton; Nina Friis-Møller; Jacquie Neuhaus; Angelike P Liappis; Andrew N Phillips
Journal:  J Acquir Immune Defic Syndr       Date:  2010-07       Impact factor: 3.731

7.  Achieving American Diabetes Association goals in HIV-seropositive patients with diabetes mellitus.

Authors:  John E Bury; Jeffrey S Stroup; Johnny R Stephens; Damon L Baker
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-04

Review 8.  Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms.

Authors:  Victor G Valcour; Cecilia M Shikuma; Michael R Watters; Ned C Sacktor
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

9.  Lipoprotein levels and cardiovascular risk in HIV-infected and uninfected Rwandan women.

Authors:  Kathryn Anastos; François Ndamage; Dalian Lu; Mardge H Cohen; Qiuhu Shi; Jason Lazar; Venerand Bigirimana; Eugene Mutimura
Journal:  AIDS Res Ther       Date:  2010-08-26       Impact factor: 2.250

Review 10.  Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.

Authors:  Erdembileg Anuurad; Alison Semrad; Lars Berglund
Journal:  Metab Syndr Relat Disord       Date:  2009-10       Impact factor: 1.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.